Figure 7

The computed inhibition zones for the antimicrobial efficiency of different doses of myco-fabricated ZnO/MnO nanocomposite against Staphylococcus epidermidis, Escherichia coli, and Candida albicans using the well-agar diffusion test, including plate images (A) and charts (C). Furthermore, the statistical analysis for the inhibitory zone diameters includes: The Box-plot graph, which compares the means for the tested pathogens (B) as well as the tested doses (D), using standard error and standard deviation boxes and whiskers via Tukey–Kramer post-hoc analysis, and (E) simultaneously Tukey tests for grouping mean differences. The tested doses of myco-fabricated ZnO/MnO nanocomposite include (a): 0 µg/ml, (b): 10 µg/ml, (c): 50 µg/ml, (d): 90 µg/ml, (e): 130 µg/ml, (f): 170 µg/ml, (g): 210 µg/ml, and (h): 250 µg/ml.